Fayos J V, Kim Y H
Radiology. 1978 Aug;128(2):471-5. doi: 10.1148/128.2.471.
A total of 145 consecutive primary testicular tumors were treated with radiation therapy at the University of Michigan Hospital from 1955 through 1974. In patients with seminoma, the 5-year survival rate was 98% for Stage I and 88% for Stage II regardless of whether retroperitoneal lymph node dissection was done. The 5-year survival rate for embryonal carcinoma was 63% for Stage I and 66% for Stage II. For teratocarcinoma it was 100% for Stage I and 54% for Stage II. Adjuvant chemotherapy appeared to be beneficial for patients with Stage II teratocarcinoma but made no difference in patients with embryonal carcinoma.
1955年至1974年期间，密歇根大学医院共对145例连续性原发性睾丸肿瘤患者进行了放射治疗。在精原细胞瘤患者中，无论是否进行腹膜后淋巴结清扫术，I期患者的5年生存率为98%，II期患者为88%。胚胎癌I期患者的5年生存率为63%，II期患者为66%。畸胎癌I期患者的5年生存率为100%，II期患者为54%。辅助化疗似乎对II期畸胎癌患者有益，但对胚胎癌患者无影响。
